SABPA

SABPA Newsletter (Sept. 2009)‏

Date:	2009-10-06
Type:	Newsletter
Organizer:	SABPA
Location:	San Diego
Source:	SABPA

Table of Content

1. SABPA OC/LA Chapter Activities

2. Board Meeting (Sep. 26, 2009, past)

3. 5th Annual SABPA Pacific Forum on Life Science Alliances (Nov. 7, 2009)

4. 5th SABPA Entrepreneur Symposium (Dec. 12, 2009)

5. Community Events & Job Listing

6. Managing Outsourced Drug Discovery (October 22 at Hilton Del Mar)

7. ACS Awards Banquet

8. PharmAsia Summit: San Francisco (Oct. 26-28 2009)

1. SABPA OC/LA Chapter Activities

With the tremendous efforts from the committee and volunteers, SABPA OC/LA Chapter has accomplished major milestones in organizational development and event planning streamline. The 4th annual Biomedical Forum was successfully held and well attended with outstanding speakers and a new venue. Several social events throughout the year, such as the May Team Social Gathering helped strengthen the team connections. Financially, the Chapter is strong. Two more committee events will be held in 2009. On event is on Biotech Outlook and the second event is on Medical Device Innovation Strategies. Any member who would like to participate in the committee, please contact Chapter President Dr. Hengchu Cao at hccao@cox.net. With the chapter president and newly elected executive vice-president recently rectified by the board, the complete chapter leadership team is list below:

President; Hengchu Cao, Edwards Lifesciences; EVP; Fred Ouyang, Allergan; Program Committee Chair : Shouyan Lee, MIM; Fund Raising Committee Chair: Jun Qiu, Allergan; Membership Committee Co-Chairs: Luo Jin, Fred Ouyang; Conference Manager: Teresa Wong, Clinical Data Consultant; University Relation Committee Chair: Bill Tang, UCI; Student Chapter Chair: Yuanfeng Wang, UCI; Secretary : Shiwei Lu; Webmaster : Henry Li, Edwards Lifesciences; Publication ; Bin Tian, Edwards Lifesciences; Treasurer: Vivian Chang, Merill Lynch; Registration: Bing Leng, GeneVault; and Joy Liu, St Jude Medical.

The SABPA OC/LA 5th Annual Biomedical Forum is scheduled to take place on April 24, 2010 in the new UCI Cardiovascular Research Center. If you know a good speaker, please contact program committee chair, Dr. Shouyan Lee at slee@angelheartintl.org.

2. Board Meeting (Sep. 26, 2009)

SABPA held its last board meeting on September 26th, 2009 at Fish & Richardson’s San Diego office. There are 17 board members from both of the San Diego chapter and the Orange County/Los Angeles chapter, along with 3 secretaries attending. Hui Cai, the chairwoman of the board welcomed all of the new members since the last election.

The meeting started with the approval of the last board meeting minutes followed by the organization reviews presented by both of the San Diego chapter president Xiangming Fang and the OC/LA chapter president Hengchu Cao. With the organization becoming more mature, an orientation folder containing 11 documents on SABPA by-laws and policies were presented to all of the board members for orientation and additional discussion. The board also confirmed the nominations of Peter Zhu as the executive vice president of the San Diego chapter and Fred Ouyang as the executive vice president of the OC/LA chapter.

Overall, both of the chapters have experienced very healthy team building, and have hosted many successful events includes our well attended 8th biopharmaceutical conference

3. 5th Annual SABPA Pacific Forum on Life Science Alliances (Nov. 7, 2009)

Mark your calendar and come join us for the highly anticipated 5th annual SABPA Pacific Forum and network with the leaders in life science across the Pacific Rim!

Date: Saturday, 8 am – 5 pm, November 07, 2009

Venue: The Institute of Americas, UCSD

Topics: The Road towards IND/NDA Filing in China and Australia / Cross-Pacific Investment and Financing Strategy / Trans-Pacific Biotech Business Opportunities and Strategies/ Science Parks in China & Taiwan

Registration: www.sabpa.org $20 by Oct 23 (early bird, $10 students & postdocs), $30 after, $50 for onsite
Click here for online registraion.

The Annual Pacific Forum organized by Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA) has provided the community an essential platform for entrepreneurs, scientists, investors, executives, and policy makers to promote life sciences and biotechnology and life science alliances across the Pacific Rim. In the last few years, Pacific Forum attracted over 300 attendees, multiple local and national media outlets, dozens of corporate sponsors, and event partners including BIOCOM and CONNECT.

This year the Forum has invited prominent industry leaders, journalist, such as Ted Plafker, bestselling author of "Doing Business in China, How to profit in the world's fastest growing market" and Beijing Correspondent for "The Economist," Joe Panetta, CEO of BIOCOM, Ivor Royston, Managing Partner of Forward Ventures, Howard Balloch, President of the Balloch Group; as well many new companies from various sectors of the life science industries in the US and China to explore the topics of cross-Pacific biotech business opportunities/strategies, IND/NDA (NCE drugs) filing in China and Australia, Investment & Financing, and science parks in China & Taiwan.

Please check our website www.sabpa.org for program updates in October. Sponsorship opportunities are available, please contact Dr. Mingzhu Zhang (email: mingzhu99@yahoo.com) for details.

4. The 5th SABPA Entrepreneur Symposium (Dec. 12, 2009)

When: 5:00 pm to 7:30 pm, Saturday, Dec. 12, 2009

Where: Institute of Americas, UCSD

Lecture title: Overview of in vitro diagnostic product development

Speaker: Dr. Larry Mimms, Vice President, R&D at Quidel Corporation and the founder of VDx LLC

5. Job opportunities at Crown Biosciences in Shanghai area, China

Associate director/director, antibody specialist (1): Crown Bioscience (Taicang) seeks an exceptionally talented and motivated individual to join a highly interactive oncology center of research and development. The core responsibilities include building and leading the antibody generation and engineering group to support project needs, planning, managing and execution of projects on hybridoma generation, antibody production and antibody engineering.

Qualifications: Ph.D. in a biology discipline, hands on experience and strong expertise in monoclonal antibody generation and antibody engineering. Experience with antibody humanization desirable but not required. Industrial experience in drug discovery is required. Good written and verbal communication skills, strong capability in technical trouble shooting. Must be able to motivate fellow team members and work with passion and enthusiasm on cancer research and development.

Associate director/director level (2), cancer cell biology: Crown Bioscience (Taicang) seeks two exceptionally talented and motivated individual to join a highly interactive oncology center of research development. The successful candidate will lead a group of cross-function scientists in cell biology, molecular biology. The main responsibilities are to identify and validate new cancer drug targets, develop and perform primary and secondary biological assays, and conduct cell-based assays to guide preclinical studies.

Qualifications: Ph.D. in cell biology with expertise in cancer biology preferred, hands on experience and strong expertise in cell biology, assay development, and screening. Industrial experience in drug discovery is required. Good written and verbal communication skills, strong capability in technical trouble shooting. Must be able to motivate fellow team members and work with passion and enthusiasm on cancer research and development.

Director of DMPK (1): The Department of Drug Metabolism and Pharmacokinetics at Crown BioScience is seeking to recruit a highly motivated Director to lead a team of bioanalytical scientists. This individual and its team will support research projects ranging from early to late stage discovery and up to proof of concept in the clinic.

Qualifications:

• A Ph.D. degree in analytical chemistry, pharmacokinetics, drug metabolism or other relevant scientific field

• At least 5 years of industrial experience

• Extensive experience in LC-MS based bioanalysis in support of drug discovery and preclinical development is required

• Excellent scientific track record as well as excellent communication and interaction skills are essential

• Experience with GLP and regulatory compliance is a plus

Associate Director/Director Oncology/Genomic/Biomarkers

The Department of Pathology, Biomarkers, Genomics, Huprime Models, In Vivo pharmacology is a Translational Cancer Pharmacology group dedicated to delivering high quality data, helping to translate preclinical research discoveries into effective therapeutics. An important part of Crownbio oncology CRO service is the use of comprehensive biomarker technologies and strategies together with our unique in vivo models (Human primary tumor xenografts) and cancer cell xenograft models to evaluate drug activity. Our translational oncology services are to determine the efficacious response (tumor shrinkage and survival), PD biomarkers, pathway specific biomarkers, endpoint biomarkers, predictive biomarkers, surrogate biomarkers. The emphasis of relevant model profiling and novel PD-biomarkers will help to drive the decision making on which drugs to bring forwards and how to dose them appropriately. We are currently looking for a highly skilled and passionate leader for our Genomic/Biomarkers group. The successful candidate will lead a large group of scientists and research associates to successfully integrate Genomics/PD-Biomarkers strategies and assays into our preclinical CRO service platforms. He/She will provide scientific leadership for the company's efforts to develop model profiling platforms, PD-biomarker strategies and novel assays to explain the drug MOA, activity and relevant biological effects in Huprime models, cancer cell line models. This candidate will be expected to form close collaborations with our Pathology/Biomarker, Target Validation, Huprime Models, In Vivo Pharmacology, DMPK groups.

Primary responsibilities are as follows:

Provide scientific leadership for the company's Genomic/Biomarker strategies and model profiling for all oncology projects. Advance the understanding of the pharmacology on client test drugs and cancer. Integrate molecular profiling and PD-markers into our joint drug development programs when appropriate. Lead the group in data analysis (trouble shooting) and report preparation for our clients. Provide first class strategic and scientific advice regarding Genomic/Oncology-Biomarkers to Senior Leadership. Drive scientific and technical innovation. Work with Departmental and Senior Leadership to prioritize Biomarker programs to ensure timely delivery of assignments for our clients.

Requirements:

PhD or M.D./PH.D. degree in relevant scientific field (e.g. Molecular Biology, Cancer biology, Molecular Oncology, Pharmacology, Pathology). A strong knowledge of genomic, molecular profiling, and PD-biomarkers and their use in defining PK/PD and dose-response relationships is attractive, but not mandatory. A minimum of 4 years post doctoral basic or preclinical drug research experience. Demonstrated record of cutting edge research as evidenced by first- or senior-authored publications in top-tiered journals. Relevant industry experience highly preferred. Excellent cross-functional team leadership and participation skills. Ability to build, lead and manage a large group of highly motivated scientists is required. Ability to lead, influence and motivate others, both within direct supervisory and matrixed environments. Ability to demonstrate effectiveness and growth in a fast-paced and dynamic environment.

6. Managing Outsourced Drug Discovery (October 22 at Hilton Del Mar)

Outsourcing drug discovery presents a less capital-intensive model for pharmaceutical research. How have your most successful colleagues done this? The symposium on Managed Outsourced Drug Discovery to be held in San Diego on October 22 at Hilton Del Mar speaks to the need in the biotech, pharma and CRO communities to stay current with best practices in drug discovery outsourcing. SABPA members have the opportunity to attend the meeting with a discount of 33%. For more information, contact RLim@PlanetConnect.com.

7. San Diego ACS Annual Awards Banquet

Date: Oct 22, 2009; 18:00-21:00
Title: Desperately Seeking Syzygy in the Land of chemoProteoPharmaceuticEconOMICS”; 2009 Distinguished Scientist Award Lecture

Speaker: Dr. John W. Kozarich, Chairman & President of ActivX Biosciences, Inc.

Place: UCSD Faculty Club - UCSD,
9500 Gilman Dr., La Jolla
see www.ucsd.edu/map/ for directions.

Park at a meter - fee required until 11PM - or use Faculty Club spaces and come into the Club and the ACS will provide a parking permit at the door.

Price: $40.00 per Dinner, $25.00 with Student I.D.
Note: there is a $5 surcharge for walk-ins to pay at the door.

RESERVATION: By Monday, October 19, 2009

You can find more information about the speaker and lecture at http://www.sandiegoacs.org

8. PharmAsia Summit: San Francisco (Oct. 26-28 2009)

Featuring the most senior experts in the Asian markets to help you take advantage of the business opportunities and avoid regulatory pitfalls in the world’s hottest emerging market. Speakers include Frank Jiang, VP- Global R&D Head, Sanofi-Aventis; Li Chen, R&D Head, Roche China; Andrew von Eschenbach, Former Commissioner, U.S. FDA; Robert Armstrong, VP, Global External Research & Development, Eli Lilly; Song Ruilin, Chairman, Chinese Journal of New Drugs; and Zhu Shen, CEO, BioForesight. This must-attend event is brought to you by PharmAsia News and Windhover Conferences, sponsor of the blockbuster Pharmaceutical Strategic Alliances. SABPA Members get $200 off! (use promotional code: SABPA).

To register, visit: www.windhover.com.